home / stock / nbio / nbio quote
Last: | $0.0999 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0999 |
Close: | $0.0999 |
High: | $0.0999 |
Low: | $0.0999 |
Volume: | 1,700 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0999 | $0.0999 | $0.0999 | $0.0999 | $0.0999 | 1,700 | 04-24-2024 |
$0.08527 | $0.09423 | $0.08527 | $0.09423 | $0.079 | 141,252 | 04-23-2024 |
$0.08985 | $0.0999 | $0.08985 | $0.0999 | $0.08 | 189,259 | 04-22-2024 |
$0.09361 | $0.09784 | $0.09361 | $0.09784 | $0.0928 | 15,510 | 04-19-2024 |
$0.09235 | $0.09235 | $0.09235 | $0.09235 | $0.09235 | 453 | 04-18-2024 |
$0.0955 | $0 | $0.0955 | $0 | $0 | 10 | 04-17-2024 |
$0.0955 | $0.1028 | $0.0955 | $0.1028 | $0.09 | 75,411 | 04-16-2024 |
$0.1197 | $0.1197 | $0.1197 | $0.1197 | $0.1197 | 300 | 04-15-2024 |
$0.10985 | $0.088 | $0.10985 | $0.10985 | $0.088 | 122,274 | 04-12-2024 |
$0.089 | $0.0888 | $0.089 | $0.089 | $0.08 | 124,400 | 04-11-2024 |
$0.0888 | $0.0888 | $0.0888 | $0.0888 | $0.0888 | 1,001 | 04-10-2024 |
$0.0888 | $0.0854 | $0.0888 | $0.0888 | $0.077 | 87,200 | 04-09-2024 |
$0.08475 | $0.12 | $0.08475 | $0.12 | $0.08 | 676,507 | 04-08-2024 |
$0.12 | $0.15 | $0.12 | $0.1501 | $0.1049 | 148,720 | 04-05-2024 |
$0.17 | $0.17 | $0.17 | $0.17 | $0.17 | 250 | 04-04-2024 |
$0.17 | $0.17 | $0.17 | $0.17 | $0.17 | 2,000 | 04-03-2024 |
$0.18 | $0.18 | $0.18 | $0.18 | $0.18 | 2,050 | 04-02-2024 |
$0.1845 | $0 | $0.1845 | $0 | $0 | 30 | 04-01-2024 |
$0.1845 | $0 | $0.1845 | $0 | $0 | 34 | 03-28-2024 |
$0.1845 | $0 | $0.1845 | $0 | $0 | 33 | 03-27-2024 |
News, Short Squeeze, Breakout and More Instantly...
NORTH PALM BEACH, FL / ACCESSWIRE / April 16, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, announces that it is embarking on a fresh manufacturin...
NORTH PALM BEACH, FL / ACCESSWIRE / March 19, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, and HypoSpray Pharma ("HypoSpray ® "), a clinical...
NORTH PALM BEACH, FL and NEW YORK, NY / ACCESSWIRE / February 6, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent"), a clinical-stage biotechnology company pioneering the development of monoclonal antibodies for the treatment of various cancers and viral infections, announc...